Who are the MHRA and what do they do?
the Medicines and Healthcare products Regulatory Agency ( MHRA ), the UK’s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness.
What is MHRA in pharma?
Medical and Healthcare Products Regulatory Agency (MHRA) is the UK regulatory authority, a government agency, for medicines and medical devices. The MHRA is responsible for the regulation of medicines and medical devices and equipment used in healthcare and the investigation of harmful incidents.
How do I contact MHRA?
For general queries about the MHRA, you can also call the MHRA Customer Service Line on 0203 080 6000 (9am to 5pm Monday to Friday).
Who is head of MHRA?
Dr June Raine
Dr June Raine has been appointed as the Medicines and Healthcare products Regulatory Agency’s (MHRA) new Chief Executive, having been the interim CEO since 2019.
Can all medicines be pre packed into a MDS?
Not all medicines and dosage regimes are suitable for MDS. Some medicines deteriorate when removed from their original packaging, and it may not be helpful to package ‘as required’ medicines into an MDS.
What is a medical device MHRA?
A medical device includes devices intended to administer a medicinal product or which incorporate as an integral part a substance which, if used separately, would be a medicinal product and which is liable to act upon the body with action ancillary to that of the device.
What is QMS in pharma?
A quality management system (QMS) is the core of any quality and compliance process. It is a regulatory requirement that the Food and Drug Administration (FDA) and other global regulatory bodies consider critical.
What is the difference between nice and MHRA?
More specifically, the MHRA advises companies on which tests are most appropriate to help cut back on costly delays and objections that could hold back a marketing authorisation application, while NICE offers product-specific scientific advice on products already in development, as well as guidance on producing …
What is yellow card in pharmacovigilance?
The Yellow Card Scheme is the United Kingdom’s system for collecting information on suspected adverse drug reactions (ADRs) to medicines. The scheme allows the safety of the medicines and vaccines that are on the market to be monitored.
Does MHRA cover Scotland?
In the Scottish context, Health Facilities Scotland (HFS) assists the MHRA in providing technical and operational support to the Scottish Government Health and Social Care Directorate and NHSScotland. The Health Innovation Assessment Portal (HIAP) is managed by NHS National Procurement.
What does pom stand for in medication?
Prescription-only medicine
Prescription-only medicine ( POM ) to pharmacy ( P ) medicine. A medicine will be non-prescription unless it fulfils the criteria for prescription control as set out below.